Abstract.
Integrins are a family of cell surface glycoproteins that mediate numerous cell-cell and cell-matrix interactions and are involved in biological processes such as tissue morphogenesis, leukocyte recirculation and migration, wound healing, blood clotting and immune response. Aberrant cell adhesion has been implicated in the pathogenesis of several diseases, including a number of inflammatory disorders such as rheumatoid arthritis, inflammatory bowel disease and asthma, as well as cancer and coronary heart disease. As such integrins are seen as excellent targets for the development of therapeutic agents. This report begins with an examination of the structure of integrin molecules and their ligands and then goes on to review the current state of development of antiintegrin antagonists.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received 13 April 1999; received after revision 28 May 1999; accepted 28 May 1999
Rights and permissions
About this article
Cite this article
Curley, G., Blum, H. & Humphries, M. Integrin antagonists. CMLS, Cell. Mol. Life Sci. 56, 427–441 (1999). https://doi.org/10.1007/s000180050443
Issue Date:
DOI: https://doi.org/10.1007/s000180050443